The inherent complexity of viral vector-based products makes their physical and biological characterization highly challenging. From a regulatory perspective, an understanding of viral vector critical quality attributes that impact product safety, purity, and potency, mean that specific, robust analytical assays are needed. In this article, Intertek’s expert Mark Redfern describes key considerations for the characterization of viral vectors including a case study focusing on the determination of empty vs full capsids.

Complete the form below to receive the case study.